-
1
-
-
0029891058
-
A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides
-
Abe A, Shayman JA, Radin NS (1996) A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides. J Biol Chem 271:14383-14389
-
(1996)
J Biol Chem
, vol.271
, pp. 14383-14389
-
-
Abe, A.1
Shayman, J.A.2
Radin, N.S.3
-
2
-
-
0038383462
-
Neutral sphingomyelinase inhibitor C11AG revents lipopolysaccharide- induced macrophage activation
-
Amtmann E, Baader W, Zoller M (2003) Neutral sphingomyelinase inhibitor C11AG revents lipopolysaccharide-induced macrophage activation. Drugs Exp Clin Res 29:5-13
-
(2003)
Drugs Exp Clin Res
, vol.29
, pp. 5-13
-
-
Amtmann, E.1
Baader, W.2
Zoller, M.3
-
3
-
-
84860724430
-
Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance
-
Antoon JW, White MD, Burow ME, Beckman BS (2012) Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncol Rep 27:1779-1786
-
(2012)
Oncol Rep
, vol.27
, pp. 1779-1786
-
-
Antoon, J.W.1
White, M.D.2
Burow, M.E.3
Beckman, B.S.4
-
4
-
-
84862740360
-
Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death
-
Apraiz A, Idkowiak-Baldys J, Nieto-Rementeria N, Boyano MD, Hannun YA, Asumendi A (2012) Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death. Biochem Cell Biol 90:209-223
-
(2012)
Biochem Cell Biol
, vol.90
, pp. 209-223
-
-
Apraiz, A.1
Idkowiak-Baldys, J.2
Nieto-Rementeria, N.3
Boyano, M.D.4
Hannun, Y.A.5
Asumendi, A.6
-
5
-
-
0035793648
-
Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase
-
Arenz C, Thutewohl M, Block O, Waldmann H, Altenbach HJ, Giannis A (2001) Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem 2: 141-143
-
(2001)
Chembiochem
, vol.2
, pp. 141-143
-
-
Arenz, C.1
Thutewohl, M.2
Block, O.3
Waldmann, H.4
Altenbach, H.J.5
Giannis, A.6
-
6
-
-
61349110856
-
Synthesis and bioevaluation of omega-N-amino analogs of B13
-
Bai A, Szulc ZM, Bielawski J, Mayroo N, Liu X, Norris J, Hannun YA, Bielawska A (2009) Synthesis and bioevaluation of omega-N-amino analogs of B13. Bioorg Med Chem 17: 1840-1848
-
(2009)
Bioorg Med Chem
, vol.17
, pp. 1840-1848
-
-
Bai, A.1
Szulc, Z.M.2
Bielawski, J.3
Mayroo, N.4
Liu, X.5
Norris, J.6
Hannun, Y.A.7
Bielawska, A.8
-
7
-
-
80054726983
-
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation
-
Baran Y, Bielawski J, Gunduz U, Ogretmen B (2011) Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation. J Cancer Res Clin Oncol 137:1535-1544
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 1535-1544
-
-
Baran, Y.1
Bielawski, J.2
Gunduz, U.3
Ogretmen, B.4
-
8
-
-
0033497270
-
Ceramide glycanase activities in human cancer cells
-
Basu M, Kelly P, O'Donnell P, Miguel M, Bradley M, Sonnino S, Banerjee S, Basu S (1999) Ceramide glycanase activities in human cancer cells. Biosci Rep 19:449-460
-
(1999)
Biosci Rep
, vol.19
, pp. 449-460
-
-
Basu, M.1
Kelly, P.2
O'Donnell, P.3
Miguel, M.4
Bradley, M.5
Sonnino, S.6
Banerjee, S.7
Basu, S.8
-
9
-
-
84856038067
-
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib
-
Beljanski V, Knaak C, Zhuang Y, Smith CD (2011) Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs 29:1132-1142
-
(2011)
Invest New Drugs
, vol.29
, pp. 1132-1142
-
-
Beljanski, V.1
Knaak, C.2
Zhuang, Y.3
Smith, C.D.4
-
10
-
-
38549169099
-
Novel analogs of D-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipids
-
Bielawska A, Bielawski J, Szulc ZM, Mayroo N, Liu X, Bai A, Elojeimy S, Rembiesa B, Pierce J, Norris JS, Hannun YA (2008) Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids. Bioorg Med Chem 16:1032-1045
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 1032-1045
-
-
Bielawska, A.1
Bielawski, J.2
Szulc, Z.M.3
Mayroo, N.4
Liu, X.5
Bai, A.6
Elojeimy, S.7
Rembiesa, B.8
Pierce, J.9
Norris, J.S.10
Hannun, Y.A.11
-
11
-
-
17544366509
-
(1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase
-
Bielawska A, Greenberg MS, Perry D, Jayadev S, Shayman JA, McKay C, Hannun YA (1996) (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem 271:12646-12654
-
(1996)
J Biol Chem
, vol.271
, pp. 12646-12654
-
-
Bielawska, A.1
Greenberg, M.S.2
Perry, D.3
Jayadev, S.4
Shayman, J.A.5
McKay, C.6
Hannun, Y.A.7
-
12
-
-
0036375662
-
Mitochondria and ceramide: Intertwined roles in regulation of apoptosis
-
Birbes H, Bawab SE, Obeid LM, Hannun YA (2002) Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv Enzyme Regul 42:113-129
-
(2002)
Adv Enzyme Regul
, vol.42
, pp. 113-129
-
-
Birbes, H.1
Bawab, S.E.2
Obeid, L.M.3
Hannun, Y.A.4
-
13
-
-
84860389588
-
PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism
-
Bourquin F, Capitani G, Grutter MG (2011) PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. Protein Sci 20:1492-1508
-
(2011)
Protein Sci
, vol.20
, pp. 1492-1508
-
-
Bourquin, F.1
Capitani, G.2
Grutter, M.G.3
-
14
-
-
0026656429
-
Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways
-
Buehrer BM, Bell RM (1992) Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways. J Biol Chem 267:3154-3159
-
(1992)
J Biol Chem
, vol.267
, pp. 3154-3159
-
-
Buehrer, B.M.1
Bell, R.M.2
-
15
-
-
84860476771
-
3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate
-
Camacho L, Simbari F, Garrido M, Abad JL, Casas J, Delgado A, Fabrias G (2012) 3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate. Bioorg Med Chem 20:3173-3179
-
(2012)
Bioorg Med Chem
, vol.20
, pp. 3173-3179
-
-
Camacho, L.1
Simbari, F.2
Garrido, M.3
Abad, J.L.4
Casas, J.5
Delgado, A.6
Fabrias, G.7
-
16
-
-
77957804651
-
Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: Probing sphingolipid signaling at the outer plasma membrane
-
Canals D, Jenkins RW, Roddy P, Hernandez-Corbacho MJ, Obeid LM, Hannun YA (2010) Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. J Biol Chem 285:32476-32485
-
(2010)
J Biol Chem
, vol.285
, pp. 32476-32485
-
-
Canals, D.1
Jenkins, R.W.2
Roddy, P.3
Hernandez-Corbacho, M.J.4
Obeid, L.M.5
Hannun, Y.A.6
-
17
-
-
79958052481
-
Drug targeting of sphingolipid metabolism: Sphingomyelinases and ceramidases
-
Canals D, Perry DM, Jenkins RW, Hannun YA (2011) Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br J Pharmacol 163:694-712
-
(2011)
Br J Pharmacol
, vol.163
, pp. 694-712
-
-
Canals, D.1
Perry, D.M.2
Jenkins, R.W.3
Hannun, Y.A.4
-
18
-
-
0035032521
-
Taxol-induced ceramide generation and apoptosis in human breast cancer cells
-
Charles AG, Han TY, Liu YY, Hansen N, Giuliano AE, Cabot MC (2001) Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 47: 444-450
-
(2001)
Cancer Chemother Pharmacol
, vol.47
, pp. 444-450
-
-
Charles, A.G.1
Han, T.Y.2
Liu, Y.Y.3
Hansen, N.4
Giuliano, A.E.5
Cabot, M.C.6
-
19
-
-
0029904184
-
Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase
-
Chatterjee S, Cleveland T, Shi WY, Inokuchi J, Radin NS (1996) Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase. Glycoconj J 13:481-486
-
(1996)
Glycoconj J
, vol.13
, pp. 481-486
-
-
Chatterjee, S.1
Cleveland, T.2
Shi, W.Y.3
Inokuchi, J.4
Radin, N.S.5
-
20
-
-
77957770455
-
Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase
-
Chumanevich AA, Poudyal D, Cui X, Davis T, Wood PA, Smith CD, Hofseth LJ (2010) Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis 31:1787-1793
-
(2010)
Carcinogenesis
, vol.31
, pp. 1787-1793
-
-
Chumanevich, A.A.1
Poudyal, D.2
Cui, X.3
Davis, T.4
Wood, P.A.5
Smith, C.D.6
Hofseth, L.J.7
-
21
-
-
51049124339
-
Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies
-
Corcoran CA, He Q, Ponnusamy S, Ogretmen B, Huang Y, Sheikh MS (2008) Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res 6:795-807
-
(2008)
Mol Cancer Res
, vol.6
, pp. 795-807
-
-
Corcoran, C.A.1
He, Q.2
Ponnusamy, S.3
Ogretmen, B.4
Huang, Y.5
Sheikh, M.S.6
-
22
-
-
61649099040
-
Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway
-
Coward J, Ambrosini G, Musi E, Truman JP, Haimovitz-Friedman A, Allegood JC, Wang E, Merrill AH Jr, Schwartz GK (2009) Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy 5:184-193
-
(2009)
Autophagy
, vol.5
, pp. 184-193
-
-
Coward, J.1
Ambrosini, G.2
Musi, E.3
Truman, J.P.4
Haimovitz-Friedman, A.5
Allegood, J.C.6
Wang, E.7
Merrill Jr., A.H.8
Schwartz, G.K.9
-
23
-
-
79954625512
-
A phase i clinical trial of safingol in combination with cisplatin in advanced solid tumors
-
Dickson MA, Carvajal RD, Merrill AH Jr, Gonen M, Cane LM, Schwartz GK (2011) A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. Clin Cancer Res 17:2484-2492
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2484-2492
-
-
Dickson, M.A.1
Carvajal, R.D.2
Merrill, Jr.A.H.3
Gonen, M.4
Cane, L.M.5
Schwartz, G.K.6
-
24
-
-
84855803916
-
Immunology in the clinic review series; Focus on cancer: Glycolipids as targets for tumour immunotherapy
-
Durrant LG, Noble P, Spendlove I (2012) Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clin Exp Immunol 167:206-215
-
(2012)
Clin Exp Immunol
, vol.167
, pp. 206-215
-
-
Durrant, L.G.1
Noble, P.2
Spendlove, I.3
-
25
-
-
0035907364
-
Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase
-
El Bawab S, Birbes H, Roddy P, Szulc ZM, Bielawska A, Hannun YA (2001) Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J Biol Chem 276:16758-16766
-
(2001)
J Biol Chem
, vol.276
, pp. 16758-16766
-
-
El Bawab, S.1
Birbes, H.2
Roddy, P.3
Szulc, Z.M.4
Bielawska, A.5
Hannun, Y.A.6
-
26
-
-
0025756765
-
Cell membrane signaling as target in cancer therapy: Inhibitory effect of N, N-dimethyl and N, N, N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice
-
Endo K, Igarashi Y, Nisar M, Zhou QH, Hakomori S (1991) Cell membrane signaling as target in cancer therapy: inhibitory effect of N, N-dimethyl and N, N, N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res 51:1613-1618
-
(1991)
Cancer Res
, vol.51
, pp. 1613-1618
-
-
Endo, K.1
Igarashi, Y.2
Nisar, M.3
Zhou, Q.H.4
Hakomori, S.5
-
27
-
-
84855791606
-
Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena
-
Fabrias G, Munoz-Olaya J, Cingolani F, Signorelli P, Casas J, Gagliostro V, Ghidoni R (2012) Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog Lipid Res 51:82-94
-
(2012)
Prog Lipid Res
, vol.51
, pp. 82-94
-
-
Fabrias, G.1
Munoz-Olaya, J.2
Cingolani, F.3
Signorelli, P.4
Casas, J.5
Gagliostro, V.6
Ghidoni, R.7
-
29
-
-
84863722443
-
C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth
-
Flowers M, Fabrias G, Delgado A, Casas J, Abad JL, Cabot MC (2011) C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth. Breast Cancer Res Treat 133:447-458
-
(2011)
Breast Cancer Res Treat
, vol.133
, pp. 447-458
-
-
Flowers, M.1
Fabrias, G.2
Delgado, A.3
Casas, J.4
Abad, J.L.5
Cabot, M.C.6
-
30
-
-
77949748845
-
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2
-
French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, Upson JJ, Green CL, Keller SN, Smith CD (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 333:129-139
-
(2010)
J Pharmacol Exp Ther
, vol.333
, pp. 129-139
-
-
French, K.J.1
Zhuang, Y.2
Maines, L.W.3
Gao, P.4
Wang, W.5
Beljanski, V.6
Upson, J.J.7
Green, C.L.8
Keller, S.N.9
Smith, C.D.10
-
31
-
-
17344380844
-
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
-
Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M, Guzman M (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313-319
-
(2000)
Nat Med
, vol.6
, pp. 313-319
-
-
Galve-Roperh, I.1
Sanchez, C.2
Cortes, M.L.3
Gomez Del Pulgar, T.4
Izquierdo, M.5
Guzman, M.6
-
32
-
-
58249129925
-
Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor
-
Granado MH, Gangoiti P, Ouro A, Arana L, Gonzalez M, Trueba M, Gomez-Munoz A (2009) Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. Cell Signal 21:405-412
-
(2009)
Cell Signal
, vol.21
, pp. 405-412
-
-
Granado, M.H.1
Gangoiti, P.2
Ouro, A.3
Arana, L.4
Gonzalez, M.5
Trueba, M.6
Gomez-Munoz, A.7
-
33
-
-
0036776990
-
Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts
-
Grazide S, Maestre N, Veldman RJ, Bezombes C, Maddens S, Levade T, Laurent G, Jaffrezou JP (2002) Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts. FASEB J 16:1685-1687
-
(2002)
FASEB J
, vol.16
, pp. 1685-1687
-
-
Grazide, S.1
Maestre, N.2
Veldman, R.J.3
Bezombes, C.4
Maddens, S.5
Levade, T.6
Laurent, G.7
Jaffrezou, J.P.8
-
34
-
-
33749544500
-
Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues
-
Grijalvo S, Bedia C, Triola G, Casas J, Llebaria A, Teixido J, Rabal O, Levade T, Delgado A, Fabrias G (2006) Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues. Chem Phys Lipids 144:69-84
-
(2006)
Chem Phys Lipids
, vol.144
, pp. 69-84
-
-
Grijalvo, S.1
Bedia, C.2
Triola, G.3
Casas, J.4
Llebaria, A.5
Teixido, J.6
Rabal, O.7
Levade, T.8
Delgado, A.9
Fabrias, G.10
-
35
-
-
40849119996
-
Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends
-
Hakomori SI (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780:325-346
-
(2008)
Biochim Biophys Acta
, vol.1780
, pp. 325-346
-
-
Hakomori, S.I.1
-
36
-
-
0022974603
-
Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets
-
Hannun YA, Loomis CR, Merrill AH Jr, Bell RM (1986) Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261:12604-12609
-
(1986)
J Biol Chem
, vol.261
, pp. 12604-12609
-
-
Hannun, Y.A.1
Loomis, C.R.2
Merrill Jr., A.H.3
Bell, R.M.4
-
37
-
-
38549152194
-
Principles of bioactive lipid signalling: Lessons from sphingolipids
-
Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 139-150
-
-
Hannun, Y.A.1
Obeid, L.M.2
-
39
-
-
84857788832
-
Defining a role for sphingosine kinase 1 in p53-dependent tumors
-
Heffernan-Stroud LA, Helke KL, Jenkins RW, De Costa AM, Hannun YA, Obeid LM (2012) Defining a role for sphingosine kinase 1 in p53-dependent tumors. Oncogene 31:1166-175
-
(2012)
Oncogene
, vol.31
, pp. 1166-1175
-
-
Heffernan-Stroud, L.A.1
Helke, K.L.2
Jenkins, R.W.3
De Costa, A.M.4
Hannun, Y.A.5
Obeid, L.M.6
-
40
-
-
79958210193
-
Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells
-
Huang H, Zhang Y, Liu X, Li Z, Xu W, He S, Huang Y, Zhang H (2011a) Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells. DNA Cell Biol 30:407-412
-
(2011)
DNA Cell Biol
, vol.30
, pp. 407-412
-
-
Huang, H.1
Zhang, Y.2
Liu, X.3
Li, Z.4
Xu, W.5
He, S.6
Huang, Y.7
Zhang, H.8
-
41
-
-
80053917915
-
Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis
-
Huang WC, Tsai CC, Chen CL, Chen TY, Chen YP, Lin YS, Lu PJ, Lin CM, Wang SH, Tsao CW, Wang CY, Cheng YL, Hsieh CY, Tseng PC, Lin CF (2011b) Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis. FASEB J 25:3661-3673
-
(2011)
FASEB J
, vol.25
, pp. 3661-3673
-
-
Huang, W.C.1
Tsai, C.C.2
Chen, C.L.3
Chen, T.Y.4
Chen, Y.P.5
Lin, Y.S.6
Lu, P.J.7
Lin, C.M.8
Wang, S.H.9
Tsao, C.W.10
Wang, C.Y.11
Cheng, Y.L.12
Hsieh, C.Y.13
Tseng, P.C.14
Lin, C.F.15
-
42
-
-
42649146192
-
New players on the center stage: Sphingosine 1- phosphate and its receptors as drug targets
-
Huwiler A, Pfeilschifter J (2008) New players on the center stage: sphingosine 1- phosphate and its receptors as drug targets. Biochem Pharmacol 75:1893-1900
-
(2008)
Biochem Pharmacol
, vol.75
, pp. 1893-1900
-
-
Huwiler, A.1
Pfeilschifter, J.2
-
43
-
-
0025027772
-
Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action
-
Inokuchi J, Jimbo M, Momosaki K, Shimeno H, Nagamatsu A, Radin NS (1990) Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res 50:6731-6737
-
(1990)
Cancer Res
, vol.50
, pp. 6731-6737
-
-
Inokuchi, J.1
Jimbo, M.2
Momosaki, K.3
Shimeno, H.4
Nagamatsu, A.5
Radin, N.S.6
-
44
-
-
62749184862
-
Roles and regulation of secretory and lysosomal acid sphingomyelinase
-
Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21:836-846
-
(2009)
Cell Signal
, vol.21
, pp. 836-846
-
-
Jenkins, R.W.1
Canals, D.2
Hannun, Y.A.3
-
45
-
-
80053427086
-
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer
-
Jiang Y, DiVittore NA, Kaiser JM, Shanmugavelandy SS, Fritz JL, Heakal Y, Tagaram HR, Cheng H, Cabot MC, Staveley-O'Carroll KF, Tran MA, Fox TE, Barth BM, Kester M (2011) Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biol Ther 12:574-585
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 574-585
-
-
Jiang, Y.1
Divittore, N.A.2
Kaiser, J.M.3
Shanmugavelandy, S.S.4
Fritz, J.L.5
Heakal, Y.6
Tagaram, H.R.7
Cheng, H.8
Cabot, M.C.9
Staveley-O'Carroll, K.F.10
Tran, M.A.11
Fox, T.E.12
Barth, B.M.13
Kester, M.14
-
46
-
-
0025045879
-
Protein kinase C and platelet inhibition by D-erythro-sphingosine: Comparison with N, N-dimethylsphingosine and commercial preparation
-
Khan WA, Dobrowsky R, el Touny S, Hannun YA (1990) Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with N, N-dimethylsphingosine and commercial preparation. Biochem Biophys Res Commun 172:683-691
-
(1990)
Biochem Biophys Res Commun
, vol.172
, pp. 683-691
-
-
Khan, W.A.1
Dobrowsky, R.2
El Touny, S.3
Hannun, Y.A.4
-
47
-
-
77952920881
-
Secretory mechanisms and intercellular transfer of microRNAs in living cells
-
Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442-17452
-
(2010)
J Biol Chem
, vol.285
, pp. 17442-17452
-
-
Kosaka, N.1
Iguchi, H.2
Yoshioka, Y.3
Takeshita, F.4
Matsuki, Y.5
Ochiya, T.6
-
48
-
-
33744953581
-
Novel tumor necrosis factorresponsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein
-
Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, KronkeM(2006) Novel tumor necrosis factorresponsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein. J Biol Chem 281:13784-13793
-
(2006)
J Biol Chem
, vol.281
, pp. 13784-13793
-
-
Krut, O.1
Wiegmann, K.2
Kashkar, H.3
Yazdanpanah, B.4
Kronke, M.5
-
49
-
-
79851470428
-
Brain pathology in Niemann Pick disease type A: Insights from the acid sphingomyelinase knockout mice
-
Ledesma MD, Prinetti A, Sonnino S, Schuchman EH (2011) Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice. J Neurochem 116: 779-788
-
(2011)
J Neurochem
, vol.116
, pp. 779-788
-
-
Ledesma, M.D.1
Prinetti, A.2
Sonnino, S.3
Schuchman, E.H.4
-
50
-
-
84863030807
-
Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis
-
Lee YS, Choi KM, Lee S, Sin DM, Lim Y, Lee YM, Hong JT, Yun YP, Yoo HS (2012) Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis. Cancer Biol Ther 13:92-100
-
(2012)
Cancer Biol Ther
, vol.13
, pp. 92-100
-
-
Lee, Y.S.1
Choi, K.M.2
Lee, S.3
Sin, D.M.4
Lim, Y.5
Lee, Y.M.6
Hong, J.T.7
Yun, Y.P.8
Yoo, H.S.9
-
51
-
-
79551468923
-
Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl + cells sensitive and resistant to STI571 through down-regulation Mcl-1
-
Li QF, Yan J, Zhang K, Yang YF, Xiao FJ, Wu CT, Wang H, Wang LS (2011) Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl + cells sensitive and resistant to STI571 through down-regulation Mcl-1. Biochem Biophys Res Commun 405:31-36
-
(2011)
Biochem Biophys Res Commun
, vol.405
, pp. 31-36
-
-
Li, Q.F.1
Yan, J.2
Zhang, K.3
Yang, Y.F.4
Xiao, F.J.5
Wu, C.T.6
Wang, H.7
Wang, L.S.8
-
52
-
-
84862739877
-
Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival
-
Lim KG, Gray AI, Pyne S, Pyne NJ (2012) Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival. Br J Pharmacol 166:1605-1616
-
(2012)
Br J Pharmacol
, vol.166
, pp. 1605-1616
-
-
Lim, K.G.1
Gray, A.I.2
Pyne, S.3
Pyne, N.J.4
-
53
-
-
79960730615
-
R-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells
-
Lim KG, Sun C, Bittman R, Pyne NJ, Pyne S (2011) (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells. Cell Signal 23:1590-1595
-
(2011)
Cell Signal
, vol.23
, pp. 1590-1595
-
-
Lim, K.G.1
Sun, C.2
Bittman, R.3
Pyne, N.J.4
Pyne, S.5
-
54
-
-
18644379261
-
Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase
-
Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277:41128-41139
-
(2002)
J Biol Chem
, vol.277
, pp. 41128-41139
-
-
Luberto, C.1
Hassler, D.F.2
Signorelli, P.3
Okamoto, Y.4
Sawai, H.5
Boros, E.6
Hazen-Martin, D.J.7
Obeid, L.M.8
Hannun, Y.A.9
Smith, G.K.10
-
56
-
-
84855609889
-
Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer
-
Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, Decensi A (2012) Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 30:151-157
-
(2012)
J Clin Oncol
, vol.30
, pp. 151-157
-
-
Macis, D.1
Gandini, S.2
Guerrieri-Gonzaga, A.3
Johansson, H.4
Magni, P.5
Ruscica, M.6
Lazzeroni, M.7
Serrano, D.8
Cazzaniga, M.9
Mora, S.10
Feroce, I.11
Pizzamiglio, M.12
Sandri, M.T.13
Gulisano, M.14
Bonanni, B.15
Decensi, A.16
-
57
-
-
0034629140
-
Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity
-
Mao C, Xu R, Bielawska A, Obeid LM (2000) Cloning of an alkaline ceramidase from Saccharomyces cerevisiae. An enzyme with reverse (CoA-independent) ceramide synthase activity. J Biol Chem 275:6876-6884
-
(2000)
J Biol Chem
, vol.275
, pp. 6876-6884
-
-
Mao, C.1
Xu, R.2
Bielawska, A.3
Obeid, L.M.4
-
58
-
-
0035854766
-
Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide
-
Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH, Obeid LM (2001) Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276:26577-26588
-
(2001)
J Biol Chem
, vol.276
, pp. 26577-26588
-
-
Mao, C.1
Xu, R.2
Szulc, Z.M.3
Bielawska, A.4
Galadari, S.H.5
Obeid, L.M.6
-
59
-
-
0038529730
-
Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism
-
Marchesini N, Luberto C, Hannun YA (2003) Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J Biol Chem 278:13775-13783
-
(2003)
J Biol Chem
, vol.278
, pp. 13775-13783
-
-
Marchesini, N.1
Luberto, C.2
Hannun, Y.A.3
-
60
-
-
0033532912
-
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines
-
Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP (1999) Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst 91:1138-1146
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1138-1146
-
-
Maurer, B.J.1
Metelitsa, L.S.2
Seeger, R.C.3
Cabot, M.C.4
Reynolds, C.P.5
-
61
-
-
0023718226
-
Inhibition of serine palmitoyltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by beta-chloroalanine
-
Medlock KA, Merrill AH Jr (1988) Inhibition of serine palmitoyltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by beta-chloroalanine. Biochemistry 27:7079-7084
-
(1988)
Biochemistry
, vol.27
, pp. 7079-7084
-
-
Medlock, K.A.1
Merrill Jr., A.H.2
-
62
-
-
33644832772
-
Targeting sphingosine-1-phosphate: A novel avenue for cancer therapeutics
-
Milstien S, Spiegel S (2006) Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell 9:148-150
-
(2006)
Cancer Cell
, vol.9
, pp. 148-150
-
-
Milstien, S.1
Spiegel, S.2
-
63
-
-
0029075192
-
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin
-
Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T (1995) Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 211:396-403
-
(1995)
Biochem Biophys Res Commun
, vol.211
, pp. 396-403
-
-
Miyake, Y.1
Kozutsumi, Y.2
Nakamura, S.3
Fujita, T.4
Kawasaki, T.5
-
64
-
-
77956231243
-
A phase 2 study of fenretinide in patients with hormone refractory prostate cancer: A trial of the Cancer Therapeutics Research Group
-
Moore MM, Stockler M, Lim R, Mok TS, Millward M, Boyer MJ (2010) A phase 2 study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group. Cancer Chemother Pharmacol 66:845-850
-
(2010)
Cancer Chemother Pharmacol
, vol.66
, pp. 845-850
-
-
Moore, M.M.1
Stockler, M.2
Lim, R.3
Mok, T.S.4
Millward, M.5
Boyer, M.J.6
-
65
-
-
48149083682
-
Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase
-
Munoz-Olaya JM, Matabosch X, Bedia C, Egido-Gabas M, Casas J, Llebaria A, Delgado A, Fabrias G (2008) Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase. Chem Med Chem 3:946-953
-
(2008)
Chem Med Chem
, vol.3
, pp. 946-953
-
-
Munoz-Olaya, J.M.1
Matabosch, X.2
Bedia, C.3
Egido-Gabas, M.4
Casas, J.5
Llebaria, A.6
Delgado, A.7
Fabrias, G.8
-
66
-
-
84863057277
-
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis
-
Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, Takabe K (2012) Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res 72:726-735
-
(2012)
Cancer Res
, vol.72
, pp. 726-735
-
-
Nagahashi, M.1
Ramachandran, S.2
Kim, E.Y.3
Allegood, J.C.4
Rashid, O.M.5
Yamada, A.6
Zhao, R.7
Milstien, S.8
Zhou, H.9
Spiegel, S.10
Takabe, K.11
-
67
-
-
0032817681
-
Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: Taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties
-
Nara F, Tanaka M, Hosoya T, Suzuki-Konagai K, Ogita T (1999a) Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties. J Antibiot (Tokyo) 52:525-530
-
(1999)
J Antibiot (Tokyo)
, vol.52
, pp. 525-530
-
-
Nara, F.1
Tanaka, M.2
Hosoya, T.3
Suzuki-Konagai, K.4
Ogita, T.5
-
68
-
-
0032866198
-
Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima
-
Nara F, Tanaka M, Masuda-Inoue S, Yamasato Y, Doi-Yoshioka H, Suzuki-Konagai K, Kumakura S, Ogita T (1999b) Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J Antibiot (Tokyo) 52:531-535
-
(1999)
J Antibiot (Tokyo)
, vol.52
, pp. 531-535
-
-
Nara, F.1
Tanaka, M.2
Masuda-Inoue, S.3
Yamasato, Y.4
Doi-Yoshioka, H.5
Suzuki-Konagai, K.6
Kumakura, S.7
Ogita, T.8
-
69
-
-
60649094611
-
Induction of apoptosis of detached oral squamous cell carcinoma cells by safingol. Possible role of Bim, focal adhesion kinase and endonuclease G
-
Noda T, Iwai S, Hamada M, Fujita Y, Yura Y (2009) Induction of apoptosis of detached oral squamous cell carcinoma cells by safingol. Possible role of Bim, focal adhesion kinase and endonuclease G. Apoptosis 14:287-297
-
(2009)
Apoptosis
, vol.14
, pp. 287-297
-
-
Noda, T.1
Iwai, S.2
Hamada, M.3
Fujita, Y.4
Yura, Y.5
-
70
-
-
79960117964
-
Novel pathway of ceramide production in mitochondria: Thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA
-
Novgorodov SA, Wu BX, Gudz TI, Bielawski J, Ovchinnikova TV, Hannun YA, Obeid LM (2011) Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA. J Biol Chem 286:25352-25362
-
(2011)
J Biol Chem
, vol.286
, pp. 25352-25362
-
-
Novgorodov, S.A.1
Wu, B.X.2
Gudz, T.I.3
Bielawski, J.4
Ovchinnikova, T.V.5
Hannun, Y.A.6
Obeid, L.M.7
-
71
-
-
84859648774
-
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
-
Ohotski J, Long JS, Orange C, Elsberger B, Mallon E, Doughty J, Pyne S, Pyne NJ, Edwards J (2012) Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer. Br J Cancer 106: 1453-1459
-
(2012)
Br J Cancer
, vol.106
, pp. 1453-1459
-
-
Ohotski, J.1
Long, J.S.2
Orange, C.3
Elsberger, B.4
Mallon, E.5
Doughty, J.6
Pyne, S.7
Pyne, N.J.8
Edwards, J.9
-
72
-
-
0028124202
-
Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation
-
Okazaki T, Bielawska A, Domae N, Bell RM, Hannun YA (1994) Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 269:4070-4077
-
(1994)
J Biol Chem
, vol.269
, pp. 4070-4077
-
-
Okazaki, T.1
Bielawska, A.2
Domae, N.3
Bell, R.M.4
Hannun, Y.A.5
-
73
-
-
0034885902
-
Sphingolipids in bacteria and fungi
-
Olsen I, Jantzen E (2001) Sphingolipids in Bacteria and Fungi. Anaerobe 7:103-112
-
(2001)
Anaerobe
, vol.7
, pp. 103-112
-
-
Olsen, I.1
Jantzen, E.2
-
74
-
-
77955393899
-
Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway
-
Park MA, Mitchell C, Zhang G, Yacoub A, Allegood J, Haussinger D, Reinehr R, Larner A, Spiegel S, Fisher PB, Voelkel-Johnson C, Ogretmen B, Grant S, Dent P (2010) Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res 70: 6313-6324
-
(2010)
Cancer Res
, vol.70
, pp. 6313-6324
-
-
Park, M.A.1
Mitchell, C.2
Zhang, G.3
Yacoub, A.4
Allegood, J.5
Haussinger, D.6
Reinehr, R.7
Larner, A.8
Spiegel, S.9
Fisher, P.B.10
Voelkel-Johnson, C.11
Ogretmen, B.12
Grant, S.13
Dent, P.14
-
75
-
-
38949105094
-
EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells
-
Paugh BS, Paugh SW, Bryan L, Kapitonov D, Wilczynska KM, Gopalan SM, Rokita H, Milstien S, Spiegel S, Kordula T (2008) EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J 22:455-465
-
(2008)
FASEB J
, vol.22
, pp. 455-465
-
-
Paugh, B.S.1
Paugh, S.W.2
Bryan, L.3
Kapitonov, D.4
Wilczynska, K.M.5
Gopalan, S.M.6
Rokita, H.7
Milstien, S.8
Spiegel, S.9
Kordula, T.10
-
76
-
-
0033059341
-
Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts
-
Payne SG, Brindley DN, Guilbert LJ (1999) Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. J Cell Physiol 180:263-270
-
(1999)
J Cell Physiol
, vol.180
, pp. 263-270
-
-
Payne, S.G.1
Brindley, D.N.2
Guilbert, L.J.3
-
77
-
-
0034708594
-
Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis
-
Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, Hannun YA (2000) Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275:9078-9084
-
(2000)
J Biol Chem
, vol.275
, pp. 9078-9084
-
-
Perry, D.K.1
Carton, J.2
Shah, A.K.3
Meredith, F.4
Uhlinger, D.J.5
Hannun, Y.A.6
-
78
-
-
84866057339
-
Selectivity and specificity of sphingosine 1-phosphate receptor ligands: Off-targets or complex pharmacology?
-
Pyne NJ, Pyne S (2011) Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology? Front Pharmacol 2:26
-
(2011)
Front Pharmacol
, vol.2
, pp. 26
-
-
Pyne, N.J.1
Pyne, S.2
-
79
-
-
84860008997
-
Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of akt
-
Qin J, Berdyshev E, Poirer C, Schwartz NB, Dawson G (2012) Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of akt. J Biol Chem 287:13620-13632
-
(2012)
J Biol Chem
, vol.287
, pp. 13620-13632
-
-
Qin, J.1
Berdyshev, E.2
Poirer, C.3
Schwartz, N.B.4
Dawson, G.5
-
80
-
-
79960127276
-
Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide
-
Rahmaniyan M, Curley RW Jr, Obeid LM, Hannun YA, Kraveka JM (2011) Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J Biol Chem 286: 24754-24764
-
(2011)
J Biol Chem
, vol.286
, pp. 24754-24764
-
-
Rahmaniyan, M.1
Curley, Jr.R.W.2
Obeid, L.M.3
Hannun, Y.A.4
Kraveka, J.M.5
-
81
-
-
77952907876
-
A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): Induction of lysosomal sphingosine kinase 1 degradation
-
Ren S, Xin C, Pfeilschifter J, Huwiler A (2010) A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p- chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation. Cell Physiol Biochem 26:97-104
-
(2010)
Cell Physiol Biochem
, vol.26
, pp. 97-104
-
-
Ren, S.1
Xin, C.2
Pfeilschifter, J.3
Huwiler, A.4
-
82
-
-
42549100356
-
The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy
-
Saad AF, Meacham WD, Bai A, Anelli V, Elojeimy S, Mahdy AE, Turner LS, Cheng J, Bielawska A, Bielawski J, Keane TE, Obeid LM, Hannun YA, Norris JS, Liu X (2007) The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 6:1455-1460
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 1455-1460
-
-
Saad, A.F.1
Meacham, W.D.2
Bai, A.3
Anelli, V.4
Elojeimy, S.5
Mahdy, A.E.6
Turner, L.S.7
Cheng, J.8
Bielawska, A.9
Bielawski, J.10
Keane, T.E.11
Obeid, L.M.12
Hannun, Y.A.13
Norris, J.S.14
Liu, X.15
-
83
-
-
79951981180
-
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration
-
Sabbadini RA (2011) Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. Br J Pharmacol 162:1225-1238
-
(2011)
Br J Pharmacol
, vol.162
, pp. 1225-1238
-
-
Sabbadini, R.A.1
-
84
-
-
34547659848
-
Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathologyin dextran sulphate sodium-induced colitis in mice
-
Sakata A, Ochiai T, Shimeno H, Hikishima S, Yokomatsu T, Shibuya S, Toda A, Eyanagi R, Soeda S (2007) Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathologyin dextran sulphate sodium-induced colitis in mice. Immunology 122:54-64
-
(2007)
Immunology
, vol.122
, pp. 54-64
-
-
Sakata, A.1
Ochiai, T.2
Shimeno, H.3
Hikishima, S.4
Yokomatsu, T.5
Shibuya, S.6
Toda, A.7
Eyanagi, R.8
Soeda, S.9
-
85
-
-
12544253058
-
Structural and functional characteristics of S1P receptors
-
Sanchez T, Hla T (2004) Structural and functional characteristics of S1P receptors. J Cell Biochem 92:913-922
-
(2004)
J Cell Biochem
, vol.92
, pp. 913-922
-
-
Sanchez, T.1
Hla, T.2
-
86
-
-
70350509103
-
Enzyme replacement therapy for Fabry disease: A systematic review of available evidence
-
Schaefer RM, Tylki-Szymanska A, Hilz MJ (2009) Enzyme replacement therapy for Fabry disease: a systematic review of available evidence. Drugs 69:2179-2205
-
(2009)
Drugs
, vol.69
, pp. 2179-2205
-
-
Schaefer, R.M.1
Tylki-Szymanska, A.2
Hilz, M.J.3
-
87
-
-
63449116281
-
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis
-
Schiffmann S, Sandner J, Schmidt R, Birod K, Wobst I, Schmidt H, Angioni C, Geisslinger G, Grosch S (2009) The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis. J Lipid Res 50:32-40
-
(2009)
J Lipid Res
, vol.50
, pp. 32-40
-
-
Schiffmann, S.1
Sandner, J.2
Schmidt, R.3
Birod, K.4
Wobst, I.5
Schmidt, H.6
Angioni, C.7
Geisslinger, G.8
Grosch, S.9
-
88
-
-
84860812174
-
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1
-
Schnute ME, McReynolds MD, Kasten T, Yates M, Jerome G, Rains JW, Hall T, Chrencik J, Kraus M, Cronin CN, Saabye M, Highkin MK, Broadus R, Ogawa S, Cukyne K, Zawadzke LE, Peterkin V, Iyanar K, Scholten JA, Wendling J, Fujiwara H, Nemirovskiy O, Wittwer AJ, Nagiec MM (2012) Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem J 444:79-88
-
(2012)
Biochem J
, vol.444
, pp. 79-88
-
-
Schnute, M.E.1
McReynolds, M.D.2
Kasten, T.3
Yates, M.4
Jerome, G.5
Rains, J.W.6
Hall, T.7
Chrencik, J.8
Kraus, M.9
Cronin, C.N.10
Saabye, M.11
Highkin, M.K.12
Broadus, R.13
Ogawa, S.14
Cukyne, K.15
Zawadzke, L.E.16
Peterkin, V.17
Iyanar, K.18
Scholten, J.A.19
Wendling, J.20
Fujiwara, H.21
Nemirovskiy, O.22
Wittwer, A.J.23
Nagiec, M.M.24
more..
-
89
-
-
0027536464
-
Protein kinase C: A novel target for inhibiting gastric cancer cell invasion
-
Schwartz GK, Jiang J, Kelsen D, Albino AP (1993) Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85:402-407
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 402-407
-
-
Schwartz, G.K.1
Jiang, J.2
Kelsen, D.3
Albino, A.P.4
-
90
-
-
0030905826
-
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
-
Schwartz GK, Ward D, Saltz L, Casper ES, Spiess T, Mullen E, Woodworth J, Venuti R, Zervos P, Storniolo AM, Kelsen DP (1997) A pilot clinical/ pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clin Cancer Res 3: 537-543
-
(1997)
Clin Cancer Res
, vol.3
, pp. 537-543
-
-
Schwartz, G.K.1
Ward, D.2
Saltz, L.3
Casper, E.S.4
Spiess, T.5
Mullen, E.6
Woodworth, J.7
Venuti, R.8
Zervos, P.9
Storniolo, A.M.10
Kelsen, D.P.11
-
91
-
-
0000717064
-
Studies on sphingolipids 7. Synthesis and configuration of natural sphingomyelins
-
Shapiro D, Flowers HM (1962) Studies on sphingolipids 7. Synthesis and configuration of natural sphingomyelins. J Am Chem Soc 84:1047-1050
-
(1962)
J Am Chem Soc
, vol.84
, pp. 1047-1050
-
-
Shapiro, D.1
Flowers, H.M.2
-
92
-
-
84862826722
-
Terpene alcohols inhibit de novo sphingolipid biosynthesis
-
Shin KO, Park MY, Seo CH, Lee YI, Kim HS, Yoo HS, Hong JT, Jung JK, Lee YM (2012) Terpene alcohols inhibit de novo sphingolipid biosynthesis. Planta Med 78:434-439
-
(2012)
Planta Med
, vol.78
, pp. 434-439
-
-
Shin, K.O.1
Park, M.Y.2
Seo, C.H.3
Lee, Y.I.4
Kim, H.S.5
Yoo, H.S.6
Hong, J.T.7
Jung, J.K.8
Lee, Y.M.9
-
93
-
-
41049100486
-
Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid
-
Somenzi G, Sala G, Rossetti S, Ren M, Ghidoni R, Sacchi N (2007) Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. PLoS One 2:e836
-
(2007)
PLoS One
, vol.2
-
-
Somenzi, G.1
Sala, G.2
Rossetti, S.3
Ren, M.4
Ghidoni, R.5
Sacchi, N.6
-
94
-
-
79957610938
-
The outs and the ins of sphingosine-1-phosphate in immunity
-
Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1- phosphate in immunity. Nat Rev Immunol 11:403-415
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 403-415
-
-
Spiegel, S.1
Milstien, S.2
-
95
-
-
0014866598
-
Studies on the biosynthesis and degradation of sphingosine bases
-
Stoffel W (1970) Studies on the biosynthesis and degradation of sphingosine bases. Chem Phys Lipids 5:139-158
-
(1970)
Chem Phys Lipids
, vol.5
, pp. 139-158
-
-
Stoffel, W.1
-
96
-
-
0034605034
-
Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death
-
Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, Kronke M, Adam D (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med 192:601-612
-
(2000)
J Exp Med
, vol.192
, pp. 601-612
-
-
Strelow, A.1
Bernardo, K.2
Adam-Klages, S.3
Linke, T.4
Sandhoff, K.5
Kronke, M.6
Adam, D.7
-
97
-
-
0016682741
-
Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase
-
Sugita M, Willians M, Dulaney JT, Moser HW (1975) Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim Biophys Acta 398:125-131
-
(1975)
Biochim Biophys Acta
, vol.398
, pp. 125-131
-
-
Sugita, M.1
Willians, M.2
Dulaney, J.T.3
Moser, H.W.4
-
98
-
-
79959790397
-
Fabry disease
-
Tarabuso AL (2011) Fabry disease. Skinmed 9:173-177
-
(2011)
Skinmed
, vol.9
, pp. 173-177
-
-
Tarabuso, A.L.1
-
99
-
-
0029791847
-
The identification of DL-threo dihydrosphingosine and sphingosine as novel inhibitors of extracellular signal-regulated kinase signalling in airway smooth muscle
-
Tolan D, Conway AM, Steele L, Pyne S, Pyne NJ (1996) The identification of DL-threo dihydrosphingosine and sphingosine as novel inhibitors of extracellular signal-regulated kinase signalling in airway smooth muscle. Br J Pharmacol 119:185-186
-
(1996)
Br J Pharmacol
, vol.119
, pp. 185-186
-
-
Tolan, D.1
Conway, A.M.2
Steele, L.3
Pyne, S.4
Pyne, N.J.5
-
100
-
-
77954535502
-
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
-
Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ (2010) FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal 22:1536-1542
-
(2010)
Cell Signal
, vol.22
, pp. 1536-1542
-
-
Tonelli, F.1
Lim, K.G.2
Loveridge, C.3
Long, J.4
Pitson, S.M.5
Tigyi, G.6
Bittman, R.7
Pyne, S.8
Pyne, N.J.9
-
101
-
-
0346363142
-
Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase
-
Triola G, Fabrias G, Casas J, Llebaria A (2003) Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase. J Org Chem 68:9924-9932
-
(2003)
J Org Chem
, vol.68
, pp. 9924-9932
-
-
Triola, G.1
Fabrias, G.2
Casas, J.3
Llebaria, A.4
-
102
-
-
9444251152
-
Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1- hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl] octanami de (GT11) in primary cultured cerebellar neurons
-
Triola G, Fabrias G, Dragusin M, Niederhausen L, Broere R, Llebaria A, van Echten-Deckert G (2004) Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1- hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl) ethyl]octanami de (GT11) in primary cultured cerebellar neurons. Mol Pharmacol 66:1671-1678
-
(2004)
Mol Pharmacol
, vol.66
, pp. 1671-1678
-
-
Triola, G.1
Fabrias, G.2
Dragusin, M.3
Niederhausen, L.4
Broere, R.5
Llebaria, A.6
Van Echten-Deckert, G.7
-
103
-
-
0035906870
-
-
Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase This work was supported by the Direccion General de Ensenanza Superior e Investigacion Cientifica (grant PB97-1171) and the Departament d'Universitats, Recerca i Societat de la Informacio, Generalitat de Catalunya (grant 1999-SGR 00187 and a Predoctoral fellowship to G.T.). We thank Dr. J. Casas, Dr. A. Delgado, and Dr. J. Joglar for their help in different aspects of this work
-
Triola G, Fabrias G, Llebaria A (2001) Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase This work was supported by the Direccion General de Ensenanza Superior e Investigacion Cientifica (grant PB97-1171) and the Departament d'Universitats, Recerca i Societat de la Informacio, Generalitat de Catalunya (grant 1999-SGR 00187 and a Predoctoral fellowship to G.T.). We thank Dr. J. Casas, Dr. A. Delgado, and Dr. J. Joglar for their help in different aspects of this work. Angew Chem Int Ed Engl 40: 1960-1962
-
(2001)
Angew Chem Int Ed Engl
, vol.40
, pp. 1960-1962
-
-
Triola, G.1
Fabrias, G.2
Llebaria, A.3
-
104
-
-
80455162314
-
Phase 2 study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: 1 report from the Children's Oncology Group
-
Villablanca JG, London WB, Naranjo A, McGrady P, Ames MM, Reid JM, McGovern RM, Buhrow SA, Jackson H, Stranzinger E, Kitchen BJ, Sondel PM, Parisi MT, Shulkin B, Yanik GA, Cohn SL, Reynolds CP (2011) Phase 2 study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clin Cancer Res 17:6858-6866
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6858-6866
-
-
Villablanca, J.G.1
London, W.B.2
Naranjo, A.3
McGrady, P.4
Ames, M.M.5
Reid, J.M.6
McGovern, R.M.7
Buhrow, S.A.8
Jackson, H.9
Stranzinger, E.10
Kitchen, B.J.11
Sondel, P.M.12
Parisi, M.T.13
Shulkin, B.14
Yanik, G.A.15
Cohn, S.L.16
Reynolds, C.P.17
-
105
-
-
33750942863
-
Solid-phase synthesis of a combinatorial library of dihydroceramide analogues and its activity in human alveolar epithelial cells
-
Villorbina G, Canals D, Carde L, Grijalvo S, Pascual R, Rabal O, Teixido J, Fabrias G, Llebaria A, Casas J, Delgado A (2007) Solid-phase synthesis of a combinatorial library of dihydroceramide analogues and its activity in human alveolar epithelial cells. Bioorg Med Chem 15:50-62
-
(2007)
Bioorg Med Chem
, vol.15
, pp. 50-62
-
-
Villorbina, G.1
Canals, D.2
Carde, L.3
Grijalvo, S.4
Pascual, R.5
Rabal, O.6
Teixido, J.7
Fabrias, G.8
Llebaria, A.9
Casas, J.10
Delgado, A.11
-
106
-
-
33644830810
-
Validation of an anti-sphingosine-1- phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
-
Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA (2006) Validation of an anti-sphingosine-1- phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9:225-238
-
(2006)
Cancer Cell
, vol.9
, pp. 225-238
-
-
Visentin, B.1
Vekich, J.A.2
Sibbald, B.J.3
Cavalli, A.L.4
Moreno, K.M.5
Matteo, R.G.6
Garland, W.A.7
Lu, Y.8
Yu, S.9
Hall, H.S.10
Kundra, V.11
Mills, G.B.12
Sabbadini, R.A.13
-
107
-
-
54049137693
-
N-(4-Hydroxyphenyl) retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
-
Wang H, Maurer BJ, Liu YY, Wang E, Allegood JC, Kelly S, Symolon H, Liu Y, Merrill AH Jr, Gouaze-Andersson V, Yu JY, Giuliano AE, Cabot MC (2008) N-(4-Hydroxyphenyl) retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol Cancer Ther 7:2967-2976
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 2967-2976
-
-
Wang, H.1
Maurer, B.J.2
Liu, Y.Y.3
Wang, E.4
Allegood, J.C.5
Kelly, S.6
Symolon, H.7
Liu, Y.8
Merrill Jr., A.H.9
Gouaze-Andersson, V.10
Yu, J.Y.11
Giuliano, A.E.12
Cabot, M.C.13
-
108
-
-
33746630883
-
Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase
-
Wascholowski V, Giannis A, Pitsinos EN (2006) Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase. ChemMedChem 1:718-721
-
(2006)
ChemMedChem
, vol.1
, pp. 718-721
-
-
Wascholowski, V.1
Giannis, A.2
Pitsinos, E.N.3
-
109
-
-
78649802553
-
Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses
-
Wu BX, Clarke CJ, Hannun YA (2010) Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses. Neuromolecular Med 12:320-330
-
(2010)
Neuromolecular Med
, vol.12
, pp. 320-330
-
-
Wu, B.X.1
Clarke, C.J.2
Hannun, Y.A.3
-
110
-
-
0030054341
-
N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets
-
Yatomi Y, Ruan F, Megidish T, Toyokuni T, Hakomori S, Igarashi Y (1996) N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35:626-633
-
(1996)
Biochemistry
, vol.35
, pp. 626-633
-
-
Yatomi, Y.1
Ruan, F.2
Megidish, T.3
Toyokuni, T.4
Hakomori, S.5
Igarashi, Y.6
-
111
-
-
0030727856
-
N, N-dimethylsphingosine 1-phosphate activates human platelets
-
Yatomi Y, Yamamura S, Ruan F, Kume S, Ozaki Y, Igarashi Y (1997) N, N-dimethylsphingosine 1-phosphate activates human platelets. FEBS Lett 417:341-344
-
(1997)
FEBS Lett
, vol.417
, pp. 341-344
-
-
Yatomi, Y.1
Yamamura, S.2
Ruan, F.3
Kume, S.4
Ozaki, Y.5
Igarashi, Y.6
-
112
-
-
0035927187
-
Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase
-
Yokomatsu T, Takechi H, Akiyama T, Shibuya S, Kominato T, Soeda S, Shimeno H (2001) Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase. Bioorg Med Chem Lett 11:1277-1280
-
(2001)
Bioorg Med Chem Lett
, vol.11
, pp. 1277-1280
-
-
Yokomatsu, T.1
Takechi, H.2
Akiyama, T.3
Shibuya, S.4
Kominato, T.5
Soeda, S.6
Shimeno, H.7
|